BioPartners GmbH Withdraws Its Application For Biferonex (interferon Beta-1a)
Links shared publicly online about this topic.
- 2,004total visits
BioPartners GmbH Withdraws Its Application For Biferonex (interferon Beta-1a)
The European Medicines Agency has been formally notified by BioPartners GmbH of its decision to withdraw its application for Biferonex (interferon beta-1a), 6 million-international-unit solution f
View full resource at medicalnewstoday.com
Tags: Multiple Sclerosis Medication, Avonex, Rebif
Most Recently Shared on May 31, 2009 at 10:23 am By:
MedNewsToday: BioPartners GmbH Withdraws Its Application For Biferonex (interferon Beta-1a): The Eu.. http://tinyurl.com/mk2dbg
Advertisement
